JERSEY CITY, NJ / ACCESSWIRE / March 30, 2015 / Aoxing Pharmaceutical Company, Inc. (NYSE MKT:AXN) ("Aoxing Pharma" or the "Company"), a specialty pharmaceutical company focusing on research, development, manufacturing, and distribution of narcotic, pain-management, and addiction treatment pharmaceuticals today announced that the Company has completed Good Manufacturing Practices ("GMP") requirements and received GMP certifications for all production lines including capsules, pills, granules, oral liquids, oral solutions, syrups, extraction, and raw material from the China State Food and Drug Administration ("SFDA").
The Company has added new production equipment to meet the stringency of the latest GMP standards and does not expect large capital expenditures in the near term. With all production lines now GMP certified, the Company can produce high quality products at a variety of formulations to meet market demands, setting the foundation for future product launches.
About Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc. is a US incorporated specialty pharmaceutical company with its operations in China, specializing in research, development, manufacturing and distribution of a variety of narcotics and pain-management products. Headquartered in Shijiazhuang City, outside Beijing, Aoxing Pharma has the largest and most advanced manufacturing facility in China for highly regulated narcotic medicines. Its facility is one of the few GMP facilities licensed for the manufacture of narcotic medicines by the SFDA. For more information, please visit: www.aoxingpharma.com.
CONTACT:
Aoxing Pharmaceutical Company
646-367-1747
investor.relations@aoxingpharma.com
SOURCE: Aoxing Pharmaceutical Company, Inc.
